Cointime

ViOptix

company

About

ViOptix, a biotech company, manufactures innovative proprietary products for tissue oximetry–measuring oxygen saturation levels in tissues.

  • 11 - 50

Highlights

Total Funding Amount
$12.20M
Funding Rounds
1
Investors
3

Details

Last Funding Type
Series D
Last Funding Money Raised
$12.20M
Industries
Biotechnology,Health Care,Manufacturing
Founded date
Jan 1, 1999
Number Of Employee
11 - 50
Operating Status
Active

ViOptix Inc. develops, manufactures and markets innovative proprietary
products for tissue oximetry, measuring oxygen saturation levels in
tissues. The Company's products and products under development consist of near infrared generators and single-use disposable sensor devices. Its first product, the ODISsey System, received U.S. Food and Drug Administration clearance in January 2005 for the measurement of localized tissue oxygenation levels for critical care applications. For more information on the Company or its products, visit the Company's website at http://www.vioptix.com.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$12.20M
ViOptix has raised a total of $12.20M in funding over 2 rounds. Their latest funding was raised on Jan 10, 2008 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 10, 2008 Series D $12.20M 3 Channel Medical Partners — Detail

Investors

Number of Lead Investors
Number of Investors
1
3
ViOptix is funded by 3 investors. Channel Medical Partners and Lincoln Funds International are the most recent investors.
Investor Name Lead Investor Funding Round
Channel Medical Partners Yes Series D
Lincoln Funds International — Series D
Canadian Medical Discoveries Fund — Series D
Cointime
Content
Company